213 related articles for article (PubMed ID: 28059950)
1. Phenotype vs. genotype in severe familial hypercholesterolemia: what matters most for the clinician?
Santos RD
Curr Opin Lipidol; 2017 Apr; 28(2):130-135. PubMed ID: 28059950
[TBL] [Abstract][Full Text] [Related]
2. Equivalent Impact of Elevated Lipoprotein(a) and Familial Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease.
Hedegaard BS; Bork CS; Kaltoft M; Klausen IC; Schmidt EB; Kamstrup PR; Langsted A; Nordestgaard BG
J Am Coll Cardiol; 2022 Nov; 80(21):1998-2010. PubMed ID: 36396201
[TBL] [Abstract][Full Text] [Related]
3. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
4. Atherosclerotic cardiovascular disease risk assessment in familial hypercholesterolemia: does one size fit all?
Mata P; Alonso R; Pérez de Isla L
Curr Opin Lipidol; 2018 Dec; 29(6):445-452. PubMed ID: 30382952
[TBL] [Abstract][Full Text] [Related]
5. Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship.
Sánchez-Hernández RM; Civeira F; Stef M; Perez-Calahorra S; Almagro F; Plana N; Novoa FJ; Sáenz-Aranzubía P; Mosquera D; Soler C; Fuentes FJ; Brito-Casillas Y; Real JT; Blanco-Vaca F; Ascaso JF; Pocovi M
Circ Cardiovasc Genet; 2016 Dec; 9(6):504-510. PubMed ID: 27784735
[TBL] [Abstract][Full Text] [Related]
6. Screening and management of familial hypercholesterolemia.
Santos RD
Curr Opin Cardiol; 2019 Sep; 34(5):526-530. PubMed ID: 31393421
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular disease onset in old people with severe hypercholesterolemia.
Coutinho ER; Miname MH; Rocha VZ; Bittencourt MS; Jannes CE; Krieger JE; Pereira AC; Santos RD
Atherosclerosis; 2023 Jan; 365():9-14. PubMed ID: 36646017
[TBL] [Abstract][Full Text] [Related]
8. Association Between Cholesterol Efflux Capacity and Atherosclerotic Cardiovascular Disease in Patients With Familial Hypercholesterolemia.
Ogura M; Hori M; Harada-Shiba M
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):181-8. PubMed ID: 26543100
[TBL] [Abstract][Full Text] [Related]
9. VEGFR2 and OPG genes modify the risk of subclinical coronary atherosclerosis in patients with familial hypercholesterolemia.
Miramontes-González JP; Usategui-Martín R; Pérez de Isla L; Alonso R; Muñiz-Grijalvo O; Díaz-Díaz JL; Zambón D; Jiménez FF; Martín-Vallejo J; Rodríguez Gude AE; Jiménez DL; Padro T; González-Sarmiento R; Mata P
Atherosclerosis; 2019 Jun; 285():17-22. PubMed ID: 30991288
[TBL] [Abstract][Full Text] [Related]
10. Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).
Pérez de Isla L; Alonso R; Mata N; Fernández-Pérez C; Muñiz O; Díaz-Díaz JL; Saltijeral A; Fuentes-Jiménez F; de Andrés R; Zambón D; Piedecausa M; Cepeda JM; Mauri M; Galiana J; Brea Á; Sanchez Muñoz-Torrero JF; Padró T; Argueso R; Miramontes-González JP; Badimón L; Santos RD; Watts GF; Mata P
Circulation; 2017 May; 135(22):2133-2144. PubMed ID: 28275165
[TBL] [Abstract][Full Text] [Related]
11. Familial hypercholesterolemia and cardiovascular disease in older individuals.
Coutinho ER; Miname MH; Rocha VZ; Bittencourt MS; Jannes CE; Tada MT; Lima IR; Filho WS; Chacra AP; Pereira AC; Krieger JE; Santos RD
Atherosclerosis; 2021 Feb; 318():32-37. PubMed ID: 33450476
[TBL] [Abstract][Full Text] [Related]
12. How Can We Identify Very High-Risk Heterozygous Familial Hypercholesterolemia?
Kataoka Y; Funabashi S; Doi T; Harada-Shiba M
J Atheroscler Thromb; 2022 Jun; 29(6):795-807. PubMed ID: 35022364
[TBL] [Abstract][Full Text] [Related]
13. The 9p21.3 locus and cardiovascular risk in familial hypercholesterolemia.
Paquette M; Chong M; Saavedra YGL; Paré G; Dufour R; Baass A
J Clin Lipidol; 2017; 11(2):406-412. PubMed ID: 28502497
[TBL] [Abstract][Full Text] [Related]
14. Derivation and validation of SIDIAP-FHP score: A new risk model predicting cardiovascular disease in familial hypercholesterolemia phenotype.
Ramos R; Masana L; Comas-Cufí M; García-Gil M; Martí-Lluch R; Ponjoan A; Plana N; Alves-Cabratosa L; Marrugat J; Elosua R; Dégano IR; Gomez-Marcos MA; Zamora A
Atherosclerosis; 2020 Jan; 292():42-51. PubMed ID: 31759248
[TBL] [Abstract][Full Text] [Related]
15. Predicting cardiovascular disease in familial hypercholesterolemia.
Paquette M; Baass A
Curr Opin Lipidol; 2018 Aug; 29(4):299-306. PubMed ID: 29708923
[TBL] [Abstract][Full Text] [Related]
16. The role of registries and genetic databases in familial hypercholesterolemia.
Kindt I; Mata P; Knowles JW
Curr Opin Lipidol; 2017 Apr; 28(2):152-160. PubMed ID: 28169870
[TBL] [Abstract][Full Text] [Related]
17. Familial hypercholesterolemia in children and the importance of early treatment.
van den Bosch SE; Hutten BA; Corpeleijn WE; Kusters DM
Curr Opin Lipidol; 2024 Jun; 35(3):126-132. PubMed ID: 38363694
[TBL] [Abstract][Full Text] [Related]
18. Homozygous familial hypercholesterolemia in childhood: Genotype-phenotype description, established therapies and perspectives.
Sanna C; Stéphenne X; Revencu N; Smets F; Sassolas A; Di Filippo M; Descamps OS; Sokal EM
Atherosclerosis; 2016 Apr; 247():97-104. PubMed ID: 26894473
[TBL] [Abstract][Full Text] [Related]
19. Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus.
Besseling J; Kastelein JJ; Defesche JC; Hutten BA; Hovingh GK
JAMA; 2015 Mar; 313(10):1029-36. PubMed ID: 25756439
[TBL] [Abstract][Full Text] [Related]
20. Familial hypercholesterolemia: experience from the French-Canadian population.
Paquette M; Genest J; Baass A
Curr Opin Lipidol; 2018 Apr; 29(2):59-64. PubMed ID: 29356704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
